

Insticator, a startup helping publishers add to their content elements like polls, quizzes and suggested story widgets, has made its first acquisition — a commenting platform called Squawk-It.
Insticator CEO Zack Dugow said his platform benefits online publishers by keeping audiences engaged and bringing in new ad revenue (which is split between Insticator and the publisher). And he sees commenting as a natural next step toward his goal to become “the main monetization and community engagement solution for publishers.”
While “don’t read the comments” remains one of the most reliable pieces of advice you’ll get online, Dugow said Squawk-It (it was formerly known as Solid Opinion) stands out from other commenting platforms because of its reliance on “100 percent human moderation,” with moderators working in three shifts to monitor partner sites 24 hours each day.
“Anybody can game an algorithm,” he said.
And when I brought up the concern that so much of the discussion has moved out of the comments section and onto social media, Dugow responded that “merging social commenting” so that it feels like everything is part of the same conversation is “in our roadmap.”
Like other Insticator products, Squawk-It comments (which you can see below the article here) are monetized through advertising. But Dugow noted that the ads run above the comments, rather than interrupting or distracting from the comments themselves.
The financial terms of the acquisition were not disclosed. Dugow said the entire 13-person Squawk-It team (headquartered in New York but with an engineering team in Kiev) has joined Insticator, and that the product has already been rebranded as Insticator Comments.
Powered by WPeMatico
In 1998, the startup company Illumina launched a revolution in the life sciences industry by developing technology to slash the costs of identifying and mapping genetic material.
Now, a little over 20 years later, Mammoth Biosciences is hoping to do the same thing for gene editing tools.
The company, co-founded by Jennifer Doudna, who did some of the pioneering work to discover the gene editing enzyme known as CRISPR, has just raised $45 million as it looks to bring to market products that can be used not only for disease detection, but are more precise editing tools for genetic material.
Rather than get bogged down in the patent dispute that raged over the provenance and ownership of applications for the original CRISPR enzyme — the Cas9 discovered by Doudna and developed for clinical applications at the Broad Institute — Mammoth has joined a number of startups in identifying new enzymes with a broader array of properties.
“From the very beginning of the company we’ve only worked with novel new enzymes to create these diagnostic products and the new novel diagnostic and editing,” says Trevor Martin, Mammoth Biosciences co-founder and chief executive.
Chiefly, the company is touting its Cas14 enzyme, which the company says opens up new possibilities for programmable biology thanks to its small size, diverse targeting ability and high fidelity — meaning that there are no unforeseen side effects to edits made using the enzyme (something that has arisen with Cas9 applications).
“There’s not one protein that’s going to be the best at everything,” says Martin. “For any particular product that you’re building, at Mammoth, we have the broadest toolbox.”
The Cas14 enzyme can be used to make gene edits in-vivo, meaning in live organisms, instead of ex-vivo, or outside of an organism. The in-vivo use-case could accelerate the time it takes to conduct experiments or develop treatments.
“Twenty years from now, when the umpteenth drug gets approved using Crispr and some nuclease named Cas132013, people are going to look back on this patent battle and think, ‘what a godawful waste of money,’ ” Jacob Sherkow a patent law scholar at New York Law School told Wired back in 2018.
Already, Horizon Discovery, a Cambridge, U.K.-based gene editing technology developer, is using the new tools developed by Mammoth Bioscience to create new CRISPR tools for Chinese Hamster Ovary cell line editing.
That partnership is an example of how Mammoth is thinking about the commercialization of the new Cas14 enzyme line and its role in biological engineering.
“You will need a full toolbox of CRISPR proteins,” says Martin. “That will allow you to interact with biology in the same way that we interact with software and computers. “From first principles, companies will programmatically modify biology to cure a disease or decrease risk for a disease. That’s going to be really kind of a turning point.”
To achieve its vision, Mammoth has managed to nab top talent from the life sciences industry, including Peter Nell, a co-founder of Casebia (a joint venture between Bayer and CRISPR Therapeutics), who came on board as chief business officer, and Ted Tisch, a former executive at Synthego and Bio-Rad, who joined the company as chief operating officer.
The company also nabbed $45 million of funding, including investment firms Mayfield, NFX, Verily (the Alphabet subsidiary) and Brook Byers, which was led by Decheng Capital — bringing the company to more than $70 million in funding.
“There are a dozen or so products that are in clinical development with CRISPR,” says Ursheet Parikh, a partner with Mayfield. “Maybe that number would go up by five or 10 without Mammoth, but it will go up by one or two orders of magnitude with Mammoth.”
To Parikh, Mammoth is the best positioned of the CRISPR development tools, because the company is building a whole platform that customers can license and use to develop products using gene editing.
The thinking, according to Parikh, is as follows, “if this technology can power lots of applications, let’s basically ensure that lots of these applications can come to market and as that happens I get my app store cut.”
“It’s an Illumina-like business,” Parikh says. “Just as anybody who is innovating with genomics needs an Illumina sequencer because they want to be able to do the sequencing… if someone wants to do editing… This gives them the access to do the right sequencing.”
Powered by WPeMatico
IBM announced today that the board of directors has elected IBM senior vice president for Cloud and Cognitive Software Arvind Krishna to replace current CEO Ginni Rometty. He will take over on April 6th after a couple of months of transition. Rometty will remain with the company as chairman of the board.
Krishna reportedly drove the massive $34 billion acquisition of Red Hat at the end of 2018, and there was some speculation at the time that Red Hat CEO Jim Whitehurst was the heir apparent, but the board went with a more seasoned IBM insider for the job, while naming Whitehurst as president.
In a statement Rometty called Krishna the right man for the job, as she steps back after more than eight years on the job. “Through his multiple experiences running businesses in IBM, Arvind has built an outstanding track record of bold transformations and proven business results, and is an authentic, values-driven leader. He is well-positioned to lead IBM and its clients into the cloud and cognitive era,” she said in a statement.
She added that in choosing Krishna and Whitehurst, the board chose a technically and business savvy team to lead the company moving forward. It’s clear that the board went with two men who have a deep understanding of cloud and cognitive computing technologies, two areas that are obviously going to be front and center of technology for the foreseeable future, and areas where IBM needs to thrive.
Ray Wang, founder and principal analyst at Constellation Research, sees the CEO-president model as a sound approach. “It’s and inside-outside model. To truly understand IBM, you have to come from the inside [like Krishna], but to truly innovate you need someone on the outside [like Whitehurst] and that CEO-president model is helping,” he said.
Patrick Moorhead, founder and principal analyst at Moor Insights & Strategies, says that he was surprised by the timing of the announcement, which seemed to come out of nowhere. “I am a bit surprised at the speed of this announcement as I don’t believe there was a formal succession plan with a named successor. IBM has always had these and it was always apparent who the next CEO would be,” he said. That was not the case this time.
But like Wang, Moorhead likes the approach of having an “outsider” and long-time IBMer working in tandem. “Krishna spearheaded many of the next-generation IBM initiatives like the Red Hat acquisition, blockchain and quantum. I am also very pleased to see Whitehurst appointed president as now there’s an outsider and a long-time IBMer running the company in the number one and two spots,” he said.
Wang believes the new leaders have to honestly assess the company’s strengths and weaknesses and find ways to compete with today’s cloud companies for the hearts and minds of the enterprise customers.
“Today IBM is in an interesting position where the world has changed, and people go to Amazon or Salesforce or they go to Google or Workday or Microsoft. Companies still have a lot of IBM, they still trust IBM, but the new leadership team needs to figure out where the technology gaps are, which ones they need to build, which ones they need to partner, and in some cases say, this is not our market,” he said.
Powered by WPeMatico
Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between.
As One Medical looks to become the first venture-backed company to price its IPO in 2020 this afternoon and Casper aims to price its own shares next Wednesday, the market is gearing up for a pair of tests.
If you listen to the Nasdaq and the NYSE, IPO volume in 2020 will prove vibrant. A surprise, perhaps, in the wake of the WeWork meltdown that many had expected might reduce IPO cadence. One Medical and Casper, though, are charging ahead, meaning that their debuts will help set the tone for the 2020 IPO market.
If they struggle with weak pricing and slow initial trading, their disappointing offerings could slow the IPO market. If they price well and are welcomed by the street, however, the opposite.
Let’s take a look at how many IPOs are coming, what One Medical and Casper are hoping for and what their results might mean for unicorn liquidity. Don’t forget that we’re still living in the midst of a unicorn liquidity crisis — there are hundreds of private companies worth $1 billion or more around the world that need an exist, and the market is creating them faster than it can get them out the door. If IPOs stumble in 2020, lots just won’t make it out before the market turns.
Yesterday, CNBC reported notes from Nasdaq CEO Adena Friedman and NYSE President Stacey Cunningham, each speaking about their expected IPO cadence in 2020. Friedman said there are “lot of companies looking to tap the public markets in the first half,” implying a strong flow of potential debuts.
Powered by WPeMatico
The Bouqs plans to take a slice of Japan’s $6 billion flower market this year with a $30 million strategic growth round from Japanese enterprise business investor Yamasa. While The Bouqs still must compete with bigger contenders like 1-800-Flowers and FTD in the U.S., it will now have to take on incumbents like Ayoma Flower Market and FloraJapan, both of which also offer same-day delivery throughout the land of the rising sun.
So why Japan? According to The Bouqs founder and CEO John Tabis, his company had been looking to expand internationally for awhile and Japan seemed to fit well within that plan.
The Bouqs CEO and founder John Tabis
But as far as bigger competition in any country, Tabis is undeterred, telling TechCrunch there’s plenty of opportunities in the flower delivery business if you know where to look. “There’ve been four or five other startups that tried something similar — some of them no longer exist,” Tabis said. “But the thing that’s worked for us, the first is the way that we’ve sourced is unique and it’s really the foundation of our brand.”
The Bouqs sprung up in a wave of Silicon Valley funded flower delivery startups like BloomThat, Farm Girl and Urban Stems, all promising Pinterest -worthy bouquets at the click of a button. But what set it apart was its farm-direct supply chain, cutting out costs from middlemen and delivering flowers that last longer.
This particular round now puts The Bouqs up top as far as total funding raised among its flower delivery startup peers, bringing in $74 million in total funding to date, with competitor Urban Stems in second place with $27 million in funding, according to Crunchbase.
Tabis also tells TechCrunch the new funds will further the company’s development into brick-and-mortar stores and that it’s jumping into the wedding biz. As anyone who’s ever planned a wedding will tell you, it’s an industry ripe for disruption — with brides and grooms spending about 8% of the budget on the flowers alone.
One other renewed focus for the company will be its subscription business, keeping customers set up with a fresh bunch of flowers once the old bouquet is ready for tossing. “It’s sort of the linchpin of our business that’s grown very nicely…expanding both our revenue and profitability,” Tabis told TechCrunch.
The SVP of Yamasa, Norikazu Sano, also mentioned further expansion into Asia for the company in a company press release, so we could see The Bouqs in more international areas over time, if all goes right in Japan.
“This financing will enable us to fully realize our vision to create a global network of top-quality farms paired with a category-defining local floral brand enabled by proprietary supply chain technology and vertically integrated sourcing capabilities. We’re so excited for this next phase of the business, and all of the opportunities that lie ahead,” Tabis said.
Powered by WPeMatico
No one ever wants to pay more, and that’s as true for well-financed companies as it is for early-stage startup founders on a shoe-string budget. So if you love robots and machine learning, why spend more on your ticket to TC Sessions: Robotics + AI 2020? Prices go up on January 31, which means you have just one day left to buy an early-bird ticket. You’ll save a tidy $150 in the process. Sweet!
On March 3, roughly 1,500 attendees will spend the day delving into the future of robots, the AI that drives them and the people at the forefront. We’re talking some of the top makers, visionaries, founders, investors and engineers. Join your community for live interviews, panel discussions, demos, workshops, audience/speaker Q&As and world-class networking.
We’ve posted the day’s agenda, and we’ll add a few more surprises in the coming weeks. Here’s a quick peek at just some of the engaging speakers and presentations you’ll enjoy:
In a classic “but wait, there’s more” moment, our Pitch Night finalists will present live on the Main Stage. Don’t know what we’re talking about? Read more about Pitch Night here, and hey — we’re accepting applications until February 1. Don’t wait — toss your hat into the ring. It’s free, and you’ll have a chance to introduce your early-stage startup to a group of heavy-hitting influencers. What’s not to love?
TC Sessions: Robotics + AI 2020 takes place on March 3. You have plenty of time to plan the day, but your opportunity to save $150 runs out in one short day. Prices go up on January 31 — buy your early-bird ticket today.
Is your company interested in sponsoring or exhibiting at TC Sessions: Robotics + AI 2020? Contact our sponsorship sales team by filling out this form.
Powered by WPeMatico
SoftBank wants its competing portfolio companies to stop losing so much money and, in some cases, to merge.
That’s the news out from Financial Times today, which reported that Uber and DoorDash discussed merging last year. The talks didn’t wind up in a deal.
The two companies, each heavily backed by SoftBank and its formerly active Vision Fund, compete in the food delivery space at great expense. Uber’s Eats business turned $392 million in adjusted net revenue in Q3 2019 into $316 million adjusted loss. That ocean of red ink actually makes DoorDash’s reported, projected $450 million 2019 operating loss look modest.
Perhaps by bringing the two companies together they would lose less money, and thus be in a better place to either return to their original IPO valuation or defend their existing private valuation.
Uber has famously struggled to retain value after its IPO, shedding worth during its public offering and since its debut. DoorDash, relatedly, was said to be in the market recently, but unable to close a new, large funding round. And as the two companies compete, a combination makes sense. Even more so when you consider their shared shareholder.
Uber and DoorDash aren’t the only examples of SoftBank-backed companies beating each other up with bricks of Vision Fund cash.
According to a report today in The Wall Street Journal, a fight in Latin America between several SoftBank-backed companies is raging:
Uber is under siege in Latin America amid a bruising price war where its ostensible rivals are Rappi and China’s Didi Chuxing Technology Co. But here’s the twist. All the combatants have as their biggest owner the same tech investor, Japan’s SoftBank Group Corp., which has injected a total of $20 billion into the three.
In the pre-unicorn era, you’ll recall the old venture maxim that no single group should invest in competing players. After all, why pay for one portfolio company to beat on another startup that you already helped finance? SoftBank, with its own investments and the Vision Fund, ignored that rule, and now it’s financing a fustercluck across the various American continents. (Though, there are some examples of other firms doing this, like Sequoia putting money into Uber and Didi.)
Which is why it might want DoorDash and Uber to link up. It might lessen one headache. Then SoftBank could work on figuring out how to keep Uber and Didi from beating each other up on rides in other markets, while disentangling Uber Eats and Rappi from a delivery scrap in yet more.
Perhaps SoftBank wants all the players to merge into a single, mega-delivery and ride corp. That would never pass regulatory oversight, of course, but at least it would centralize the losses and cash burn into a single income statement.
Think of the time it would save!
Powered by WPeMatico
The European parliament has voted overwhelmingly for tougher action to reduce e-waste, calling for the Commission to come up with beefed up rules by July 2020.
Specifically, the parliament wants the Commission to adopt the delegated act foreseen in the 2014 Radio Equipment Directive by that deadline — or else table a legislative measure by the same date, at the latest.
The resolution, which was approved by 582 votes to 40, points out that MEPs have been calling for a single charger for mobile devices for more than a decade now. But the Commission has repeatedly postponed taking steps to force an industry-wide shift. Subtext: We’re tired of the ongoing charging cable nightmare.
The parliament says there is now “an urgent need” for EU regulatory action on the issue — to shrink e-waste, empower consumers to make sustainable choices, and allow EU citizens to “fully participate in an efficient and well-functioning internal market”.
The resolution notes that around 50 million metric tons of e-waste is generated globally per year, with an average of more than 6 kg per person.
While, in Europe in 2016, the figure for total e-waste generated was 12.3 million metric tonnes, equivalent to 16.6 kg on average per inhabitant — with the parliament asserting this represents “an unnecessary environmental footprint that can be reduced”.
To date, the Commission’s approach to the charger e-waste issue has been to lean on industry to take voluntary steps to reduce unnecessary variety. Which has resulted in a reduction of the number of charger types on the market — down from 30+ in 2009 to just three today — but still no universal charger which works across brands and device types (phones, tablets, e-readers etc).
Most notably, Apple continues to use its own Lightning port charger standard — while other device makers have switched to USB-based charging (such as the newest, USB-C standard).
When news emerged earlier this month of the parliament’s intention to vote on tougher measures to standardize mobile chargers Apple attacked the plan — arguing that regulation would ‘stifle innovation’.
But the tech giant has had plenty of years to chew over clever ways to switch from the proprietary charging port only it uses to one of two USB standards used by everyone else. So the ‘innovation’ argument seems a pretty stale one.
Meanwhile Apple has worked around previous EU attempts to push device makers to standardize charging on Micro USB by expanding its revenue-generating dongle collection — and selling Europeans a Lighting to Micro USB adaptor. Thereby necessitating even more e-waste.
Perhaps picking up on Apple’s ‘innovation’ framing sidestep, i.e. to try to duck the e-waste issue, the parliament also writes:
… that the Commission, without hampering innovation, should ensure that the legislative framework for a common charger will be scrutinised regularly in order to take into account technical progress; reiterates the importance of research and innovation in this domain to improve existing technologies and come up with new ones;
It also wants the Commission to grapple with the issue of wireless chargers — and take steps to ensure interoperability there too, so that wireless chargers aren’t locked to only one brand or device type.
Consumers should not be obliged to buy new chargers with each new device, per the resolution, with the parliament calling on the Commission to introduce strategies to decouple the purchase of chargers from a new device alongside a common charger solution — while making sure any decoupling measures do not result in higher prices for consumers.
It also wants the Commission to look at legislative options for increasing the volume of cables and chargers that are collected and recycled in EU member states.
We’ve reached out to the Commission for comment.
Per Reuters, officials in the executive are in agreement that the voluntary approach is not working and have said they plan to introduce legislation for a common charger this year.
Powered by WPeMatico
During the Federal Aviation Administration’s (FAA) 23rd annual Commercial Space Transportation Conference in Washington, D.C., one panel focused on the changing regulatory environment when it comes to private launch activities, and how those are integrated into existing rules and practices for managing commercial air transportation. Panelist Caryn Schenewerk, SpaceX senior counsel and senior director of space flight policy, emphasized that while the company always does the utmost to ensure safety in everything it does, the company also wants to focus on the actual state of the industry today and how it needs to grow as various partners work to establish new rules for the growing commercial launch sector.
“When aviation started, the Wright brothers weren’t flying over major populated cities,” Schenewerk pointed out. “They were outside Paris in an unpopulated field, and they were at Kitty Hawk on unpopulated beaches. And they were in Ohio in unpopulated areas.”
Schenewerk was directly addressing comments made by other panelists, and specifically ALPA Aviation Safety Chair Steve Jangelis, that suggested the emerging commercial launch industries may be looking far ahead to when they’re launching from spaceports located near populated areas, and launching with much more frequency than they are today. In general, Jangelis was advocating for laying the groundwork now for high levels of cooperation and integration between aviation traffic management and rocket launch operators.
Schenewerk was reluctant to concede any kind of direct equivalency between the commercial air transportation industry and the space launch sector, given their relative dissimilarity.
She noted that in terms of sheer volume, there’s a massive difference, with roughly 40 to 50 launches set for 2020 compared to millions of flights for commercial air. Airlines also use essentially the same small handful of airframes from suppliers like Boeing and Airbus, while each launch company has their own, very different vehicle with different conditions for launch and flight. Overall, she suggested then that anticipating some potential future state where the industries were more similar could result in stifling progress toward that ultimate goal.
“I hope we get to that million launches at some point, but when we are at that point, it’s going to be because we worked our way up the safety trajectory in a way that allows us to operate that way,” Schenewerk said. “Today, SpaceX can’t fly from a spaceport in the middle of the country, because we won’t get through the safety approval. We literally will not be licensed by the FAA to operate from that site, because we will then be flying over large populations of people — and we aren’t at that level of reliability and safety in this industry to fly over large populations of people with these kinds of rockets. Could we get there someday? Yeah, we can get there someday when we’ve had a million flights, and a million prove-outs of our capability, when we have such repeatability that we’re in that level.”
Ultimately, Schenewerk’s comments and Jangelis’ responses illustrate that there are still a lot of places where younger companies and emerging technologies like reusable rocket launches are conflicting with the views of more established industries and players operating in some shared spaces.
FAA Administrator Steve Dickson also addressed the agency’s ongoing work to establish launch rules, which were released as a draft last year and which Dickson said will likely be finalized sometime this fall, once the FAA has incorporated industry comments and feedback.
“Let’s think about that big vision, that big day when lots of things are happening,” Schenewerk said. “But let’s also not yell at our kid for not being able to fly an airplane when they can barely walk — and I think that’s where we are right now: We’re still figuring out how to walk and run in this industry.”
Powered by WPeMatico
There comes a time for many founders when they are ready to pass the baton of running their business to someone else. It’s a rare founder who wants to go from zero to running and scaling a large, long-term company. When that time comes — you may have expectations on what you would like to exit for, or have read stories about other company valuations — I thought it might be useful to share some of the other side’s viewpoint. So, here are some of the criteria we use at Scaleworks when evaluating a new opportunity.
The cliche is “rule number two: read rule number one.” Make sure any acquisition you consider is at a fair price and that you have identified some low-hanging fruit opportunities for improvement that you are confident in your ability to execute on.
What does a fair price mean?
For us, it means a price we have confidence we can either pay back over time from cash flow, or sell the business on a profit multiple for at least the same price we bought it for.
Powered by WPeMatico